Study Supports PreMD's Breast Cancer Detection Technology

Armen Hareyan's picture

PreMD data shows increased reactivity in nipple aspirate fluid from breast cancer patients. The abstract, entitled, 'Galactose oxidase Schiff's (GOS) reactivity is higher in nipple aspirate fluid from cancerous breasts than from healthy patients,' was presented by Dr. Anees B. Chagpar from the University of Louisville.

"This is a very interesting study that could influence how testing for breast cancer is performed in the future," said Brent Norton, president and chief executive officer of PreMD Inc. "With additional research, our

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.